EPI2ME end-to-end workflows for biopharma quality control of plasmids and mRNA
- shared.published_on: May 19 2026

Sample preparation, bespoke basecalling and medaka models, the Q-Line GridION device, and EPI2ME analysis workflows are revolutionising quality control (QC) in biopharma.
Download the poster to find out:
- How Oxford Nanopore end-to-end workflows could replace traditional QC methods
- More about what Q-Line GridION offers when it comes to QC assays
- About the plasmid QC workflow
- About the mRNA QC workflow for mRNA products, such as vaccines
